Glycopyrrolate Injection
Product Images NDC 51662-1425

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 51662-1425). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 mL Serialized Vial Labeling 51662-1425-1 (1425 1 Serialized Vial Labeling)

GLYCOPYRROLATE Injection USP 0.2 mg/mL is shown in a 1 mL single dose vial with a red cap. The vial label states it contains benzyl alcohol and is for intramuscular or intravenous use. The product is distributed by HF Acquisition Co LLC, DBA HealthFirst.*

FDA Label Image

51662-1425-1 Vial Label (1425 1 Vial Label)

Glycopyrrolate Injection, USP 0.2 mg/mL single dose vial label. This intramuscular or intravenous injectable contains benzyl alcohol as a preservative. It is a 1 mL vial manufactured by Amneal Biosciences LLC and distributed by HF Acquisition Co LLC, DBA HealthFirst. Storage instructions specify 20° to 25°C (68° to 77°F). Barcode and lot/expiration area included.*

FDA Label Image

5 mL Serialized Vial Labeling 51662-1431-1 (1431 1 Serailzed Vial Labeling)

Clear glass vial of Glycopyrrolate Injection, USP, 1 mg/5 mL (0.2 mg/mL) multiple dose vial with a purple flip-off cap. The label shows the NDC 70121-1396-1 and states the product is for intramuscular or intravenous administration. Distributed by HF Acquisition Co LLC, DBA HealthFirst.*

FDA Label Image

51662-1431-1 5 mL Vial Label (1431 1 Vial Labeling)

Label for Glycopyrrolate Injection, USP 1 mg/5 mL (0.2 mg/mL) multiple dose vial. Injection containing benzyl alcohol for intramuscular or intravenous use. Includes warnings such as 'Not for use in newborns.' Manufactured by Amneal Pharmaceuticals and distributed by Amneal Biosciences LLC. Label includes lot and expiration area with barcode.*

FDA Label Image

Clinical Tabel (Clinical Tabel 1)

A data table comparing pharmacokinetic parameters of Glycopyrrolate Injection administered intravenously (6 mcg/kg) versus intramuscularly (8 mcg/kg). It presents half-life (t1/2), volume of distribution (Vss), clearance (CL), time to maximum concentration (Tmax), maximum concentration (Cmax), and area under the curve (AUC) with mean values and variability for each administration route over 0 to 8 hours.*

FDA Label Image

Structure (Structure)

Chemical structure of glycopyrrolate, a muscarinic receptor antagonist. The diagram shows the molecular arrangement including a quaternary ammonium group, ester linkage, and cyclopentyl and phenyl rings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.